Abstract
In PD patients, the most beneficial effect on motor symptoms can be achieved with the use of bilateral subthalamic nucleus DBS (DBS STN), which also significantly improves quality of life. The favourable effect of DBS STN on quality of life has been proven in multicentre randomised trials, but there is no clear evidence of its influential effect on the disease progression in PD in humans. Therefore the aim of the study was to evaluate the possible alterations in disease progression in patients with advanced stage PD, who underwent bilateral DBS STN, in comparison to PD patients treated with best medical therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
